JP2023528300A5 - - Google Patents
Info
- Publication number
- JP2023528300A5 JP2023528300A5 JP2022571787A JP2022571787A JP2023528300A5 JP 2023528300 A5 JP2023528300 A5 JP 2023528300A5 JP 2022571787 A JP2022571787 A JP 2022571787A JP 2022571787 A JP2022571787 A JP 2022571787A JP 2023528300 A5 JP2023528300 A5 JP 2023528300A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant rna
- rna replicon
- item
- coding region
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032000P | 2020-05-29 | 2020-05-29 | |
| US63/032,000 | 2020-05-29 | ||
| PCT/US2021/034787 WO2021243172A1 (en) | 2020-05-29 | 2021-05-28 | Encapsulated rna replicons and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528300A JP2023528300A (ja) | 2023-07-04 |
| JP2023528300A5 true JP2023528300A5 (https=) | 2024-06-04 |
Family
ID=78722848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022571787A Withdrawn JP2023528300A (ja) | 2020-05-29 | 2021-05-28 | 封入されたｒｎａレプリコンおよび使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230416308A1 (https=) |
| EP (1) | EP4157456A4 (https=) |
| JP (1) | JP2023528300A (https=) |
| KR (1) | KR20230019450A (https=) |
| CN (1) | CN115666722A (https=) |
| AU (1) | AU2021281357A1 (https=) |
| CA (1) | CA3180557A1 (https=) |
| WO (1) | WO2021243172A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20240586T1 (hr) | 2018-10-09 | 2024-07-19 | The University Of British Columbia | Sastavi i sustavi koji sadrže transfekcijske sposobne vezikle bez organskih otapala i deterdženta i s njim povezanim postupcima |
| AU2023259636A1 (en) * | 2022-04-29 | 2024-10-10 | Elevatebio Technologies, Inc. | Production of rna polynucleotides encoding picornavirus |
| WO2023223183A1 (en) * | 2022-05-16 | 2023-11-23 | Crispr Therapeutics Ag | Picornaviral vectors for gene editing |
| EP4704872A2 (en) * | 2023-05-05 | 2026-03-11 | Mayo Foundation for Medical Education and Research | Methods and materials for treating cancer |
| WO2025072371A2 (en) * | 2023-09-27 | 2025-04-03 | The General Hospital Corporation | Highly active myeloid therapy |
| CN118460614B (zh) * | 2024-07-05 | 2025-03-11 | 凌意(杭州)生物科技有限公司 | 一种腺相关病毒Cap蛋白的表达框 |
| ES3058740A1 (es) * | 2025-08-01 | 2026-03-12 | Univ Valencia Politecnica | Nanopartícula lipídica, composición farmacéutica y uso de la nanopartícula en el tratamiento del cáncer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030040498A1 (en) * | 2001-03-14 | 2003-02-27 | Ansardi David Calvert | Oncolytic RNA replicons |
| US20030077251A1 (en) * | 2001-05-23 | 2003-04-24 | Nicolas Escriou | Replicons derived from positive strand RNA virus genomes useful for the production of heterologous proteins |
| WO2008027560A2 (en) * | 2006-09-01 | 2008-03-06 | Anza Therapeutics, Inc. | Holin-enhanced vaccines and reagents, and methods of use thereof |
| JP6396891B2 (ja) * | 2013-04-17 | 2018-09-26 | 新日本製薬株式会社 | 遺伝子改変コクサッキーウイルス |
| MA41506A (fr) * | 2015-02-13 | 2017-12-19 | Takeda Vaccines Inc | Procédés de production de virus pour produire des vaccins |
| KR20200036873A (ko) * | 2017-07-14 | 2020-04-07 | 온코루스, 인크. | 캡슐화된 폴리뉴클레오티드 및 사용 방법 |
| CA3116192C (en) * | 2018-11-06 | 2025-09-23 | Calidi Biotherapeutics (Nevada), Inc. | IMPROVED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY |
-
2021
- 2021-05-28 CA CA3180557A patent/CA3180557A1/en active Pending
- 2021-05-28 US US17/999,582 patent/US20230416308A1/en active Pending
- 2021-05-28 CN CN202180038250.2A patent/CN115666722A/zh active Pending
- 2021-05-28 AU AU2021281357A patent/AU2021281357A1/en not_active Abandoned
- 2021-05-28 EP EP21812110.1A patent/EP4157456A4/en not_active Withdrawn
- 2021-05-28 JP JP2022571787A patent/JP2023528300A/ja not_active Withdrawn
- 2021-05-28 WO PCT/US2021/034787 patent/WO2021243172A1/en not_active Ceased
- 2021-05-28 KR KR1020227045616A patent/KR20230019450A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023528300A5 (https=) | ||
| JP2022516318A5 (https=) | ||
| JP2024503623A5 (https=) | ||
| JP7776176B2 (ja) | 環状ｒｎａを調製するための構築物及び方法 | |
| JP2021525076A5 (https=) | ||
| EP4141111A1 (en) | Oncolytic virus vaccine and drug for treating tumors by combining oncolytic virus vaccine with immune cells | |
| JP2023526495A5 (https=) | ||
| JP2022512912A5 (https=) | ||
| JP2018531023A5 (https=) | ||
| JP2023523414A5 (https=) | ||
| JPWO2012053646A1 (ja) | ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム／ブーストワクチン用ウイルスベクター | |
| CN118556131A (zh) | 用于蛋白质表达的mRNA及其模板 | |
| Ciré et al. | Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo | |
| JP2005508610A (ja) | 異種タンパク質の製造に有用なプラス鎖ｒｎａウイルスゲノムに由来するレプリコン | |
| JP2004501646A5 (https=) | ||
| JP2023521662A5 (https=) | ||
| JP2023542297A5 (https=) | ||
| WO2025102994A1 (zh) | 基于i型内含子的rna体外环化与滚环翻译的方法及其应用 | |
| WO2025002153A1 (zh) | 树突状细胞靶向的类病毒体dvlp及其制备方法和应用 | |
| AU2023307937A1 (en) | Encrypted rna and methods of its use | |
| JP2024542126A (ja) | 自己増幅ｒｎａ組成物及びその使用方法 | |
| JP2024503703A5 (https=) | ||
| Von Messling et al. | Toward novel vaccines and therapies based on negative-strand RNA viruses | |
| KR100686356B1 (ko) | 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제 | |
| WO2025016031A1 (zh) | 自扩增核酸分子及其应用 |